Skip to main content
OpenTrials

Clinical trial condition

T-cell Lymphoma

Explore clinical trials studying T-cell Lymphoma. Study availability and eligibility vary by location and protocol.

34 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

T-cell Lymphoma trial results

Recruiting

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

NCT06390319

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • Novant Health Presbyterian Hemby Children's Hospital Charlotte, North Carolina, United States
  • Saint Francis Children's Hospital Tulsa, Oklahoma, United States
  • St. Jude Children's Research Hospital Memphis, Tennessee, United States
View Trial Details
Recruiting

CD4CAR for CD4+ Leukemia and Lymphoma

NCT03829540

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • Albert Einstein Health Network New York, United States
View Trial Details
Recruiting

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

NCT06131801

Conditions
ALL, AML, Acute Lymphocytic Leukemia, +50 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details
Recruiting

A Registry for People With T-cell Lymphoma

NCT05978141

Conditions
Adult T-Cell Leukemia/Lymphoma, Aggressive NK-cell Leukemia, Anaplastic Large Cell Lymphoma, ALK-Positive, +54 more
Locations
  • City of Hope Cancer Center (Data collection only) Duarte, California, United States
  • UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only) San Diego, California, United States
  • University of California San Francisco (Data collection only) San Francisco, California, United States
  • Stanford University Medical Center (Data collection only) Stanford, California, United States
View all 26 locations
View Trial Details
Recruiting

A Study of Enasidenib in People With T-Cell Lymphoma

NCT06756308

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Dana Farber Cancer Institute (Data Collection Only) Boston, Massachusetts, United States
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
View Trial Details
Recruiting

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

NCT04752826

Conditions
Adnexal Diseases, Advanced Malignancies, Endocrine Gland Neoplasms, +33 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Rigshospitalet Copenhagen, Denmark
View all 25 locations
View Trial Details
Recruiting

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

NCT04234048

Conditions
Angioimmunoblastic T-cell Lymphoma, Cutaneous T-Cell Lymphoma, Cutaneous T-Cell Lymphoma, Unspecified, +23 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • City of Hope Medical Foundation Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
View Trial Details

Related conditions